Evive Biotech

Evive Biotech is a global biologics company developing a range of novel biotherapies for patients and healthcare worldwide. We leverage our proprietary technology platforms to provide a series of innovative drug candidates for oncology and inflammatory diseases. Founded in 2004, the company now has over 200 employees in the United States, Singapore, and China. We adopt a holistic approach to drug development, combining exceptional research and commercialization capabilities with world-class in-house regulatory expertise to bring innovative therapies to market quickly and efficiently. Our state-of-the-art in-house cGMP facilities enable us to conduct commercial-scale manufacturing in compliance with FDA, EMA, and NMPA standards and industry best practices. Through collaboration with industry, physicians, and regulatory authorities, we develop revolutionary treatments that we believe will bring real and lasting change to patients and their families around the world.